LIGAND PHARMACEUTICALS INCORPORATED
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 94.9% | 40.3% | -1.5% |
| FY2017 | 96.2% | 48.2% | 8.9% |
| FY2018 | 97.5% | 65.1% | 57.0% |
| FY2019 | — | 671.0% | 523.2% |
| FY2020 | — | 22.9% | -1.8% |
| FY2021 | — | 43.0% | 23.7% |
| FY2022 | — | 1.5% | -17.0% |
| FY2023 | — | 9.1% | 39.7% |
| FY2024 | — | -13.5% | -2.4% |
| FY2025 | — | 15.3% | 46.4% |